volume 36 issue 12 pages 1613-1618

The Efficacy of Oral Ribavirin in the Treatment of Crimean-Congo Hemorrhagic Fever in Iran

Publication typeJournal Article
Publication date2003-06-15
scimago Q1
wos Q1
SJR2.992
CiteScore21.0
Impact factor7.3
ISSN10584838, 15376591
PubMed ID:  12802764
Microbiology (medical)
Infectious Diseases
Abstract
We compared the mortality rate among patients suspected of having Crimean-Congo hemorrhagic fever (CCHF) who received treatment with oral ribavirin and those who did not. Ninety-seven (69.8%) of 139 treated patients suspected of having CCHF survived, and 61 (88.9%) of 69 treated patients with confirmed CCHF survived. The efficacy of oral ribavirin was 80% among patients with confirmed CCHF and 34% among patients suspected of having CCHF. Considering the limitations of observational studies, we conclude that oral ribavirin is an effective treatment for the hemorrhagic form of CCHF.
Found 
Found 

Top-30

Journals

2
4
6
8
10
12
Antiviral Research
12 publications, 8.28%
International Journal of Infectious Diseases
7 publications, 4.83%
Journal of Infection
5 publications, 3.45%
Vector-Borne and Zoonotic Diseases
4 publications, 2.76%
Clinical Infectious Diseases
4 publications, 2.76%
Journal of Virology
4 publications, 2.76%
International Journal of Infection
3 publications, 2.07%
Tropical Doctor
2 publications, 1.38%
BMC Infectious Diseases
2 publications, 1.38%
Comparative Immunology, Microbiology and Infectious Diseases
2 publications, 1.38%
Cochrane Database of Systematic Reviews
2 publications, 1.38%
Journal of Antimicrobial Chemotherapy
2 publications, 1.38%
Iranian Red Crescent Medical Journal
1 publication, 0.69%
Emerging Infectious Diseases
1 publication, 0.69%
Journal of Medical Microbiology
1 publication, 0.69%
Current Medical Imaging Reviews
1 publication, 0.69%
Future Virology
1 publication, 0.69%
Oncotarget
1 publication, 0.69%
Applied Biosafety
1 publication, 0.69%
Reviews in Medical Microbiology
1 publication, 0.69%
Current Opinion in Infectious Diseases
1 publication, 0.69%
Pediatric Infectious Disease Journal
1 publication, 0.69%
South African Family Practice
1 publication, 0.69%
Therapeutic Advances in Respiratory Disease
1 publication, 0.69%
Viruses
1 publication, 0.69%
Pathogens
1 publication, 0.69%
Nature Medicine
1 publication, 0.69%
Indian Journal of Hematology and Blood Transfusion
1 publication, 0.69%
Archives of Virology
1 publication, 0.69%
2
4
6
8
10
12

Publishers

10
20
30
40
50
60
Elsevier
53 publications, 36.55%
Springer Nature
13 publications, 8.97%
Wiley
9 publications, 6.21%
Oxford University Press
8 publications, 5.52%
American Society for Microbiology
8 publications, 5.52%
Taylor & Francis
6 publications, 4.14%
SAGE
4 publications, 2.76%
Mary Ann Liebert
4 publications, 2.76%
Ovid Technologies (Wolters Kluwer Health)
4 publications, 2.76%
Brieflands
4 publications, 2.76%
MDPI
2 publications, 1.38%
DoNotEdit
1 publication, 0.69%
Centers for Disease Control and Prevention (CDC)
1 publication, 0.69%
Microbiology Society
1 publication, 0.69%
Bentham Science Publishers Ltd.
1 publication, 0.69%
Impact Journals
1 publication, 0.69%
Public Library of Science (PLoS)
1 publication, 0.69%
1 publication, 0.69%
Publications Office of the European Union
1 publication, 0.69%
Korean Society of Infectious Diseases and Korean Society for Chemotherapy
1 publication, 0.69%
The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS
1 publication, 0.69%
Asian Network for Scientific Information
1 publication, 0.69%
Cambridge University Press
1 publication, 0.69%
Walter de Gruyter
1 publication, 0.69%
Science Alert
1 publication, 0.69%
BMJ
1 publication, 0.69%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.69%
Modestum Ltd
1 publication, 0.69%
10
20
30
40
50
60
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
145
Share
Cite this
GOST |
Cite this
GOST Copy
Mardani M. et al. The Efficacy of Oral Ribavirin in the Treatment of Crimean-Congo Hemorrhagic Fever in Iran // Clinical Infectious Diseases. 2003. Vol. 36. No. 12. pp. 1613-1618.
GOST all authors (up to 50) Copy
Mardani M., Jahromi M. K., Naieni K. H., Zeinali M. The Efficacy of Oral Ribavirin in the Treatment of Crimean-Congo Hemorrhagic Fever in Iran // Clinical Infectious Diseases. 2003. Vol. 36. No. 12. pp. 1613-1618.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1086/375058
UR - https://doi.org/10.1086/375058
TI - The Efficacy of Oral Ribavirin in the Treatment of Crimean-Congo Hemorrhagic Fever in Iran
T2 - Clinical Infectious Diseases
AU - Mardani, Masoud
AU - Jahromi, M K
AU - Naieni, K H
AU - Zeinali, M.
PY - 2003
DA - 2003/06/15
PB - Oxford University Press
SP - 1613-1618
IS - 12
VL - 36
PMID - 12802764
SN - 1058-4838
SN - 1537-6591
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2003_Mardani,
author = {Masoud Mardani and M K Jahromi and K H Naieni and M. Zeinali},
title = {The Efficacy of Oral Ribavirin in the Treatment of Crimean-Congo Hemorrhagic Fever in Iran},
journal = {Clinical Infectious Diseases},
year = {2003},
volume = {36},
publisher = {Oxford University Press},
month = {jun},
url = {https://doi.org/10.1086/375058},
number = {12},
pages = {1613--1618},
doi = {10.1086/375058}
}
MLA
Cite this
MLA Copy
Mardani, Masoud, et al. “The Efficacy of Oral Ribavirin in the Treatment of Crimean-Congo Hemorrhagic Fever in Iran.” Clinical Infectious Diseases, vol. 36, no. 12, Jun. 2003, pp. 1613-1618. https://doi.org/10.1086/375058.